NALTREXONE IN YOUNG AUTISTIC CHILDREN: A DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER STUDY
-д хадгалсан:
KOLMEN, B.K., ET AL., NALTREXONE IN YOUNG AUTISTIC CHILDREN: A DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER STUDY. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, Vol. 34, no. 2 (1995), p. 223-231.
Ref.
47812
Байршил:
SIIS SIIS Madrid R.598
Palabras clave:
Autismo, Ceguera, Discapacidad, Discapacidad del lenguaje, Discapacidad intelectual, Fármacos, Trastornos del espectro autista, Tratamiento
Autismo, Ceguera, Discapacidad, Discapacidad del lenguaje, Discapacidad intelectual, Fármacos, Trastornos del espectro autista, Tratamiento
Ижил төстэй зүйлс: NALTREXONE IN YOUNG AUTISTIC CHILDREN: A DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER STUDY
- A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER PILOT TRIAL OF LOW DOSE DIMETHYLGLYCINE IN PATIENTS WITH AUTISTIC DISORDER
- EFFECTS OF NALOXONE AND NALTREXONE ON SELF-INJURY: A DOUBLE-BLIND, PLACEBO-CONTROLLED ANALYSIS
- MULTISITE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PORCINE SECRETIN IN AUTISM
- HIGH-DOSE PYRIDOXINE AND MAGNESIUM ADMINISTRATION IN CHILDREN WITH AUTISTIC DISORDER: AN ABSENCE OF SALUTARY EFFECTS IN A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
- NALTREXONE IN YOUNG AUTISTIC CHILDREN: REPLICATION STUDY AND LEARNING MEASURES
- A CONTROLLED CROSSOVER TRIAL OF FENFLURAMINE IN AUTISM